IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mabvax Therapeutics Holdings I

Q1 2016 vs Q2 2016

Comparing institutional holders between quarters

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Biomark Capital Management Co. LLC
UNCHANGED
Shares197,641 from 197,641
Change0 (0%)
Value$119 (-$23)
Filed 2016-08-12
Geduld E E
UNCHANGED
Shares20,000 from 20,000
Change0 (0%)
Value$11 (-$3)
Filed 2016-08-08
Status
Biomark Capital Management Co. LLC
UNCHANGED197,641197,64100%$142$119-$232016-08-12
Geduld E E
UNCHANGED20,00020,00000%$14$11-$32016-08-08
Showing 2 of 2 institutions